FLUSHING TOWNSHIP, Michigan -- Jennifer Szwed is hoping 15 minutes of fame will help end a lifetime of very private pain.
Painful sex, menopause, diarrhea and chronic pelvic pain are the kind of intensely personal topics that women usually keep to themselves.
But plagued with chronic endometriosis, uninsured, unable to work and unable to afford the $20,000 surgery to cure it, the Flushing Township mom wants to bare all by turning for help to talk show hosts, reality TV and Internet-based social networking.
SAN DIEGO – Neurocrine Biosciences said Tuesday it will lay off half of its 120 employees to conserve cash and move its midstage experimental drugs through clinical studies.
The San Diego biotechnology company has about $89 million in cash, which at its current burn rate would last about 18 months. But Neurocrine is hoping to move its lead drug candidate, elagolix, into costly late-stage clinical studies, and has yet to forge an alliance with a drug company to share those costs.
Objective To evaluate the short- and long-term outcomes of laparoscopic colorectal resection for endometriosis.
Design and Patients This study included 357 consecutive patients who underwent colorectal resection. We evaluated intraoperative and postoperative complications, symptom outcomes, and long-term follow-up.
Main Outcome Measure Three hundred forty-three patients (96.1%) underwent laparoscopic colorectal resection, and radical endometriosis ablation was in 334 patients (93.6%).
